AI may expand access to eating disorder support, but significant challenges remain. New research explores where these tools ...

In the last few decades, the prevalence of eating disorders (EDs), characterized by maladaptive eating behaviors such as extreme calorie restriction, binge-eating, and self-induced vomiting, has ...

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

Despite their prevalence, eating disorders (EDs) are under-researched and often misunderstood. A recent focus of research on the biological underpinnings of EDs has helped to reframe our understanding ...

GLP-1 medications suppress appetite. What they cannot do is tell whether that appetite was disordered to begin with. For some ...